Literature DB >> 19800678

Novel relationship of serum cholesterol with asthma and wheeze in the United States.

Michael B Fessler1, Mark W Massing, Brian Spruell, Renee Jaramillo, David W Draper, Jennifer H Madenspacher, Samuel J Arbes, Agustin Calatroni, Darryl C Zeldin.   

Abstract

BACKGROUND: Cholesterol exerts complex effects on inflammation. There has been little investigation of whether serum cholesterol is associated with asthma, an inflammatory airways disease with great public health impact.
OBJECTIVE: To determine relationships between levels of 3 serum cholesterol measures (total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], and non-HDL-C) and asthma/wheeze in a sample representative of the US population.
METHODS: Cross-sectional study of 7005 participants age >or=6 years from the 2005 to 2006 National Health and Nutrition Examination Survey.
RESULTS: Serum TC and non-HDL-C were lower in patients with current asthma than in subjects without current asthma in the overall population (TC, 188.5 vs 192.2 mg/dL; non-HDL-C, 133.9 vs 137.7 mg/dL; P < .05 for both), whereas HDL-C was not different. Adjusted odds ratios (ORs) from multivariate logistic regression per 1-SD increase of TC and non-HDL-C for current asthma were 0.92 (95% CI, 0.86-0.98) and 0.91 (95% CI, 0.85-0.98), respectively. On racial/ethnic stratification, these relationships reflect marked reductions unique to Mexican Americans (MAs; TC, 171.4 vs 189.3 mg/dL; P < .001; OR, 0.62; 95% CI, 0.48-0.80; non-HDL-C, 119.8 vs 137.9 mg/dL; P < .001; OR, 0.62; 95% CI, 0.48-0.79). Among MAs, the adjusted OR for wheeze requiring medical attention was 0.57 (95% CI, 0.43-0.75) for TC and 0.53 (95% CI, 0.33-0.85) for non-HDL-C. Relationships between cholesterol and asthma/wheeze were independent of body mass index and serum C-reactive protein, and similar between atopic and nonatopic participants.
CONCLUSION: Serum TC and non-HDL-C are inversely related to asthma in the US population, chiefly reflecting a relationship among MAs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800678      PMCID: PMC3936400          DOI: 10.1016/j.jaci.2009.08.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  46 in total

1.  Asthma mortality in U.S. Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995.

Authors:  D M Homa; D M Mannino; M Lara
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Comparison of frequency of coronary artery calcium in healthy Hispanic versus non-Hispanic white men by electron beam computed tomography.

Authors:  Peter D Reaven; Dewayne Thurmond; Alisa Domb; Richard Gerkin; Matthew J Budoff; Steven Goldman
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

3.  Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.

Authors:  Michael H Davidson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09       Impact factor: 8.311

4.  Intake of unsaturated fatty acids and HDL cholesterol levels are associated with manifestations of atopy in adults.

Authors:  T Schäfer; S Ruhdorfer; L Weigl; D Wessner; J Heinrich; A Döring; H-E Wichmann; J Ring
Journal:  Clin Exp Allergy       Date:  2003-10       Impact factor: 5.018

5.  Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity.

Authors:  Dunia Rodríguez; Alexandre C Keller; Eliana L Faquim-Mauro; Mahasti S de Macedo; Fernando Q Cunha; Jean Lefort; B Boris Vargaftig; Momtchilo Russo
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

6.  The health of Latino children: urgent priorities, unanswered questions, and a research agenda.

Authors:  Glenn Flores; Elena Fuentes-Afflick; Oxiris Barbot; Olivia Carter-Pokras; Luz Claudio; Marielena Lara; Jennie A McLaurin; Lee Pachter; Francisco J Ramos-Gomez; Fernando Mendoza; R Burciaga Valdez; Antonia M Villarruel; Ruth E Zambrana; Robert Greenberg; Michael Weitzman; Francisco J Ramos Gomez
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

7.  Activation of mast cells by incorporation of cholesterol into rafts.

Authors:  Thomas Baumruker; Robert Csonga; Edith Pursch; Andrea Pfeffer; Nicole Urtz; Sue Sutton; Elisa Bofill-Cardona; Michael Cooke; Eva Prieschl
Journal:  Int Immunol       Date:  2003-10       Impact factor: 4.823

8.  Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data.

Authors:  A A Arif; G L Delclos; E S Lee; S R Tortolero; L W Whitehead
Journal:  Eur Respir J       Date:  2003-05       Impact factor: 16.671

9.  Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.

Authors:  Daniel Cruz; Andrew D Watson; Christopher S Miller; Dennis Montoya; Maria-Teresa Ochoa; Peter A Sieling; Miguel A Gutierrez; Mohamad Navab; Srinivasa T Reddy; Joseph L Witztum; Alan M Fogelman; Thomas H Rea; David Eisenberg; Judith Berliner; Robert L Modlin
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.

Authors:  E J Hothersall; R Chaudhuri; C McSharry; I Donnelly; J Lafferty; A D McMahon; C J Weir; J Meiklejohn; N Sattar; I McInnes; S Wood; N C Thomson
Journal:  Thorax       Date:  2008-08-29       Impact factor: 9.139

View more
  23 in total

1.  Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population.

Authors:  Michael B Fessler; Kathryn Rose; Yanmei Zhang; Renee Jaramillo; Darryl C Zeldin
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 2.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 3.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

4.  Emerging roles for cholesterol and lipoproteins in lung disease.

Authors:  Kymberly M Gowdy; Michael B Fessler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-15       Impact factor: 3.410

5.  Metabolomics reveals altered metabolic pathways in experimental asthma.

Authors:  Wanxing Eugene Ho; Yong-Jiang Xu; Fengguo Xu; Chang Cheng; Hong Yong Peh; Steven R Tannenbaum; W S Fred Wong; Choon Nam Ong
Journal:  Am J Respir Cell Mol Biol       Date:  2012-11-09       Impact factor: 6.914

6.  Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes.

Authors:  Jennifer H Madenspacher; David W Draper; Kathleen A Smoak; Haitao Li; Gary L Griffiths; Benjamin T Suratt; Martha D Wilson; Lawrence L Rudel; Michael B Fessler
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

Review 7.  Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research.

Authors:  Amir A Zeki; Nicholas J Kenyon; Tzipora Goldkorn
Journal:  Drug Metab Lett       Date:  2011-01

8.  Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Authors:  Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

9.  Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control study.

Authors:  Jun Tsukiji; Soo Jung Cho; Ghislaine C Echevarria; Sophia Kwon; Phillip Joseph; Edward J Schenck; Bushra Naveed; David J Prezant; William N Rom; Ann Marie Schmidt; Michael D Weiden; Anna Nolan
Journal:  Biomarkers       Date:  2014-02-19       Impact factor: 2.658

10.  Being overweight increases susceptibility to indoor pollutants among urban children with asthma.

Authors:  Kim D Lu; Patrick N Breysse; Gregory B Diette; Jean Curtin-Brosnan; Charles Aloe; D'Ann L Williams; Roger D Peng; Meredith C McCormack; Elizabeth C Matsui
Journal:  J Allergy Clin Immunol       Date:  2013-02-10       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.